JP2012500205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012500205A5 JP2012500205A5 JP2011523131A JP2011523131A JP2012500205A5 JP 2012500205 A5 JP2012500205 A5 JP 2012500205A5 JP 2011523131 A JP2011523131 A JP 2011523131A JP 2011523131 A JP2011523131 A JP 2011523131A JP 2012500205 A5 JP2012500205 A5 JP 2012500205A5
- Authority
- JP
- Japan
- Prior art keywords
- alkoxy
- alkylamino
- heteroaryl
- cycloalkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8821708P | 2008-08-12 | 2008-08-12 | |
| US61/088,217 | 2008-08-12 | ||
| PCT/US2009/053524 WO2010019646A1 (en) | 2008-08-12 | 2009-08-12 | Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012500205A JP2012500205A (ja) | 2012-01-05 |
| JP2012500205A5 true JP2012500205A5 (enExample) | 2012-09-27 |
| JP5546540B2 JP5546540B2 (ja) | 2014-07-09 |
Family
ID=41165710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523131A Expired - Fee Related JP5546540B2 (ja) | 2008-08-12 | 2009-08-12 | スフィンゴシン‐１‐リン酸（ｓ１ｐ）レセプター拮抗薬およびその使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8049037B2 (enExample) |
| EP (1) | EP2328863A1 (enExample) |
| JP (1) | JP5546540B2 (enExample) |
| KR (1) | KR20110044893A (enExample) |
| CN (1) | CN102119140B (enExample) |
| AU (1) | AU2009282017B2 (enExample) |
| BR (1) | BRPI0918399A2 (enExample) |
| CA (1) | CA2733970A1 (enExample) |
| RU (1) | RU2505527C2 (enExample) |
| WO (1) | WO2010019646A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8802692B2 (en) | 2008-10-17 | 2014-08-12 | Exelixis, Inc. | Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
| US8168795B2 (en) * | 2009-08-11 | 2012-05-01 | Allergan, Inc. | Selective sphingosine-1-phosphate receptor antagonists |
| WO2011028927A1 (en) * | 2009-09-04 | 2011-03-10 | Allergan, Inc. | Selective sphingosine-1-phosphate receptor antagonists |
| JP2013533286A (ja) * | 2010-07-30 | 2013-08-22 | セントルイス ユニバーシティ | 疼痛を治療する方法 |
| KR101625872B1 (ko) | 2015-01-27 | 2016-06-01 | 국민대학교산학협력단 | 스마트단말기의 이벤트 기반의 차량조명 제어시스템 및 그 제어방법, 그리고 이를 위한 컴퓨터로 판독가능한 기록매체 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE756062A (fr) * | 1969-09-11 | 1971-03-11 | Boehringer Sohn Ingelheim | Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides |
| JPS55111451A (en) | 1979-02-19 | 1980-08-28 | Nippon Kayaku Co Ltd | Novel 2-hydroxybenzamide derivative and agricultural and horticultural soil bactericide |
| EP0146810A3 (de) | 1983-12-05 | 1987-05-13 | Solco Basel AG | Verfahren zur Herstellung von Sphingosinderivaten |
| JPS61172860A (ja) * | 1985-01-28 | 1986-08-04 | Nippon Kayaku Co Ltd | 新規ピリジン誘導体及びそれを有効成分とする農園芸用細菌病防除剤 |
| US4659722A (en) * | 1984-08-20 | 1987-04-21 | Nippon Kayaku Kabushiki Kaisha | Bactericidal N-(2,2,2 trichloroethyl)pyridinecarboxamides |
| US5110987A (en) | 1988-06-17 | 1992-05-05 | Emory University | Method of preparing sphingosine derivatives |
| ZA902794B (en) | 1989-04-18 | 1991-04-24 | Duphar Int Res | New 3-n substituted carbamoyl-indole derivatives |
| US5294722A (en) | 1992-04-16 | 1994-03-15 | E. R. Squibb & Sons, Inc. | Process for the preparation of imidazoles useful in angiotensin II antagonism |
| US5403851A (en) | 1994-04-05 | 1995-04-04 | Interneuron Pharmaceuticals, Inc. | Substituted tryptamines, phenalkylamines and related compounds |
| ATE314342T1 (de) | 1997-03-12 | 2006-01-15 | Takara Bio Inc | Spingosinanaloga |
| ATE332888T1 (de) | 1997-09-11 | 2006-08-15 | Takara Bio Inc | Sphingosinderivate und medizinische zubereitung |
| AU5322399A (en) * | 1998-07-27 | 2000-02-21 | President And Fellows Of Harvard College | Method of high-throughput screening of molecules and compounds for their effectson biological and chemical processes |
| CA2422044A1 (en) * | 2000-09-14 | 2002-03-21 | Gliatech, Inc. | Nitrogen-containing compounds and their use as glycine transport inhibitors |
| JP2004529100A (ja) * | 2001-01-30 | 2004-09-24 | ユニバーシティ オブ バージニア パテント ファウンデーション | スフィンゴシン−１−ホスフェートレセプターのアゴニストおよびアンタゴニスト |
| AU2002310099A1 (en) * | 2001-05-22 | 2002-12-03 | President And Fellows Of Harvard College | Identification of anti-protozoal agents |
| US7074817B2 (en) | 2001-06-20 | 2006-07-11 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| GB0324210D0 (en) * | 2003-10-15 | 2003-11-19 | Novartis Ag | Organic compounds |
| GB0405289D0 (en) * | 2004-03-09 | 2004-04-21 | Novartis Ag | Organic compounds |
-
2009
- 2009-08-12 EP EP09791415A patent/EP2328863A1/en not_active Withdrawn
- 2009-08-12 BR BRPI0918399A patent/BRPI0918399A2/pt not_active IP Right Cessation
- 2009-08-12 US US12/539,906 patent/US8049037B2/en not_active Expired - Fee Related
- 2009-08-12 WO PCT/US2009/053524 patent/WO2010019646A1/en not_active Ceased
- 2009-08-12 CN CN200980140468.8A patent/CN102119140B/zh not_active Expired - Fee Related
- 2009-08-12 RU RU2011108713/04A patent/RU2505527C2/ru not_active IP Right Cessation
- 2009-08-12 CA CA2733970A patent/CA2733970A1/en not_active Abandoned
- 2009-08-12 JP JP2011523131A patent/JP5546540B2/ja not_active Expired - Fee Related
- 2009-08-12 KR KR1020117005619A patent/KR20110044893A/ko not_active Withdrawn
- 2009-08-12 AU AU2009282017A patent/AU2009282017B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010525056A5 (enExample) | ||
| JP2016528301A5 (enExample) | ||
| JP2013519675A5 (enExample) | ||
| JP2012041349A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| JP2010524932A5 (enExample) | ||
| HRP20151017T1 (hr) | Polimorfi i soli n-[5-[4-(5-{[(2r,6s)-2,6-dimetil-4-morfolinil]metil}-1,3-oksazol-2-il)-1h-indazol-6-il]-2-(metiloksi)-3-piridinil]metansulfonamida | |
| HRP20180916T1 (hr) | Inhibitori demetilaze od lsd1 na bazi arilciklopropilamina i njihova medicinska uporaba | |
| JP2012500205A5 (enExample) | ||
| JP2011528713A5 (enExample) | ||
| JP2009535352A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2016506960A5 (enExample) | ||
| IL202018A (en) | 4,2-Difluoro-n- {2- (Methylaoxy) -5- [4- (4-Pyridazinyl) -6-Quinolinyl] -3-Pyridinyl} Benzenesulfonamide, its Pharmaceuticals and Its Use in the Treatment of Pi3 Kinase-Related Diseases | |
| JP2016534063A5 (enExample) | ||
| JP2012506872A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| EP2046430A4 (en) | ADMINISTRATION OF ANTI-THERAPY | |
| EP2051760A4 (en) | ADMINISTRATION OF ANTI-THERAPY | |
| JP2015512931A5 (enExample) | ||
| EP2151435A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| JP2016526558A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| JP2010077141A5 (enExample) |